According to the study, adding vildagliptin to premixed insulin effectively reduced blood glucose levels & glycemic variability in T2DM patients.
Nevertheless, clinicians should be cautious about the potential hypoglycemia due to vildagliptin.
In three diabetic papillopathy cases, intravitreal bevacizumab with oral steroids achieved rapid disc edema resolution, OCT-confirmed RNFL thinning, marked gains in visual field and acuity, and no intraocular pressure rise or adverse events.